1. Academic Validation
  2. Potentiation of macrophage Piezo1 by atherogenic 7-ketocholesterol

Potentiation of macrophage Piezo1 by atherogenic 7-ketocholesterol

  • Cell Rep. 2025 Apr 22;44(4):115542. doi: 10.1016/j.celrep.2025.115542.
Edyta Glogowska 1 Gregor P Jose 1 Ana Rita Dias Araújo 1 Malika Arhatte 1 Raphael Divita 1 Coraline Borowczyk 2 Thibault Barouillet 2 Baile Wang 3 Frédéric Brau 1 Rémi Peyronnet 4 Amanda Patel 1 Bruno Mesmin 1 Takeshi Harayama 1 Bruno Antonny 1 Aimin Xu 3 Laurent Yvan-Charvet 2 Eric Honoré 5
Affiliations

Affiliations

  • 1 Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Institut de Pharmacologie Moléculaire et Cellulaire, Labex ICST, 06560 Valbonne, France.
  • 2 Institut National de la Santé et de la Recherche Médicale, Inserm, Université Côte d'Azur, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, Fédération Hospitalo-Universitaire (FHU) Oncoage, Nice, France.
  • 3 State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China.
  • 4 Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg - Bad Krozingen, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • 5 Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Institut de Pharmacologie Moléculaire et Cellulaire, Labex ICST, 06560 Valbonne, France; State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China. Electronic address: honore@ipmc.cnrs.fr.
Abstract

The mechanosensitive ion channel Piezo1 present in endothelial and smooth muscle cells, as well as in macrophages, is emerging as a novel, important player in the etiology of atherosclerosis. Here, we show that myeloid-specific deficiency of Piezo1 in atherogenic LDLR-/- mice reduces plaque formation. Moreover, chronic oxLDL, as well as its main oxysterol 7-ketocholesterol (7-KC), promotes Piezo1 opening by pressure stimulation in both mouse macrophages and transfected HEK cells. 7-KC dramatically enhances Piezo1 current amplitude and slows down inactivation and deactivation. This up-modulation involves an increase in Piezo1 expression, as well as a potentiation of mechanical gating that depends on membrane Cholesterol depletion and decreased order. By contrast, Piezo1 is inhibited by the athero-protective free docosahexaenoic acid, either without or with 7-KC. Altogether, these findings indicate that macrophage Piezo1 is differentially modulated by pro- and anti-atherogenic lipids, pointing to the role of Piezo1 and its potentiation by oxysterols in atherosclerosis.

Keywords

7-ketocholesterol; CP: Cell biology; CP: Metabolism; PUFAs; atherosclerosis; cholesterol; docosahexaenoic acid; ion channels; macrophage; mechanobiology; oxLDL; patch clamp.

Figures